Stryker

Stryker Stock-Based Compensation

The Stock-Based Compensation (SBC) of Stryker (SYK) as of Nov 3, 2026 is 243.00 M USD. In the previous year, Stock-Based Compensation (SBC) was 229.00 M USD — a change of 6.11% (higher).

Stock-Based Compensation

243.00 MUSD

YoY

6.11%

Last updated:

Stock-Based Compensation (SBC) of Stryker is 2025 243.00 M USD. Stock-Based Compensation (SBC) of Stryker was 2024 229.00 M USD. It decreases by 6.11% higher compared to the previous year.

The Stryker Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2018
119.00 M USD
Jan 1, 2019
127.00 M USD
Jan 1, 2020
142.00 M USD
Jan 1, 2021
171.00 M USD
Jan 1, 2022
168.00 M USD
Jan 1, 2023
205.00 M USD
Jan 1, 2024
229.00 M USD
Jan 1, 2025
243.00 M USD
The Stryker Stock-Based Compensation history
YEARStock-Based CompensationYoY
243.00 MUSD+6.11%
229.00 MUSD+11.71%
205.00 MUSD+22.02%
168.00 MUSD-1.75%
171.00 MUSD+20.42%
142.00 MUSD+11.81%
127.00 MUSD+6.72%
119.00 MUSD+5.31%
113.00 MUSD+16.49%
97.00 MUSD+12.79%
86.00 MUSD+11.69%
77.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stryker Stock analysis

What does Stryker do? Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stryker stock

Stock-Based Compensation (SBC) of Stryker is 243.00 M USD in 2025.

Stock-Based Compensation (SBC) of Stryker changed from 229.00 M USD to 243.00 M USD, representing a 6.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Stryker since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Stryker historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Stryker

All Key Metrics — Stryker